Skip to search formSkip to main contentSkip to account menu

Lopid

Known as: Lipur, Lopid R 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Gemfibrozil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
LOPID (Gemfibrozil Tablets, USP)
  • 2017
  • Corpus ID: 44822173
DESCRIPTION LOPID (gemfibrozil tablets, USP) is a lipid regulating agent. It is available as tablets for oral administration… 
2016
2016
β-Cyclodextrin anchoring onto pericarpium granati-derived magnetic mesoporous carbon for selective capture of lopid in human serum and pharmaceutical wastewater samples.
1999
1999
Evaluation of kidney and liver subacute toxicity induced by bezalip ‐ pravastatin. Lopid antihyperlipidaemic compounds in rats
Renal and hepatic subacute toxicity induced by the antihyperlipidaemic drugs: Bezalip ‐ Pravastatin and Lopid was investigated in… 
1997
1997
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale…
1995
1995
Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study.
Hyperlipidemia is a common side-effect of oral retinoid treatment, which sometimes interferes with long-term therapy. To evaluate… 
1993
1993
Once-daily, extended-release gemfibrozil in patients with dyslipidemia. The Lopid SR Work Group I.
1991
1991
[Side effects of fibrates (except liver and muscle)].
If the iatrogenic acute muscular syndromes (rhabdomyolysis) and hepatic diseases following hypolipidemic drugs therapy are very… 
1990
1990
Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemias.
In 25 patients with primary dyslipoproteinemias and severe premature atherosclerosis, during an average combined Lopid-Mevacor… 
1989
1989
Eruptive xanthomas in a child with the nephrotic syndrome.
1982
1982
Long-Term Use of Gemfibrozil (Lopid®) in the Treatment of Dyslipidemia
This report describes the results of long-term treatment for blood lipid regulation with a new drug, gemfibrozil (Lopid®). During… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License